Zheng Quan Shi Bao Wang·2025-06-11 01:57Core Insights - The total margin financing balance for the ChiNext market reached 344.136 billion yuan, marking a continuous increase for six trading days, with a cumulative increase of 5.784 billion yuan during this period [1][2]. Margin Financing Balance Overview - As of June 10, 2025, the total margin financing balance was 345.070 billion yuan, with an increase of 0.321 billion yuan from the previous trading day [2]. - The margin financing balance specifically was 344.136 billion yuan, which increased by 0.342 billion yuan from the previous day [2]. Individual Stock Performance - During the period of increasing margin financing, 559 stocks saw an increase in their financing balances, with 56 stocks experiencing an increase of over 20% [2]. - The stock with the highest increase in financing balance was Dahongli, which saw an increase of 111.16%, bringing its latest financing balance to 56.0291 million yuan [3]. - Conversely, 374 stocks experienced a decrease in their financing balances, with 42 stocks declining by over 10%. The largest decrease was seen in Lulian Technology, which dropped by 38.36% [3]. Sector Performance - Stocks with financing balance increases of over 20% were primarily concentrated in the pharmaceutical, machinery, and basic chemical industries, with 14, 7, and 7 stocks respectively [5]. Market Performance - Stocks with financing balance increases of over 20% averaged a rise of 12.00%, outperforming the ChiNext index. Notable gainers included Kangli Source, Changshan Pharmaceutical, and Xice Testing, with increases of 64.82%, 34.93%, and 33.42% respectively [5]. - The largest increases in financing balances by amount were recorded by Sifang Jingchuang (1.305 billion yuan), followed by Juguang Technology (300 million yuan) and Lepu Medical (252 million yuan) [5].